# NexImmune, Inc. (NEXI)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NEXI/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -5.68M | $ -4.72M | $ 0 | $ 920.5K |
| 2023 | $ 2.29M | $ -34.97M | $ -86.66M | $ 68.8K | $ 3.51M |
| 2022 | $ 0 | $ -69.58M | $ -58.59M | $ 1.02M | $ 32.30M |
| 2021 | $ 0 | $ -60.50M | $ -57.22M | $ 0 | $ 83.76M |
| 2020 | $ 0 | $ -38.05M | $ -34.74M | $ 19.12M | $ -15.75M |
| 2019 | $ 0 | $ -6.61M | $ -6.61M | $ 0 | $ 10.61M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 5.37 |
| Current Ratio | 0.66 |

## Other views

- [Metrics](https://sponda.capital/en/NEXI.md)
- [Charts](https://sponda.capital/en/NEXI/charts.md)
- [Compare](https://sponda.capital/en/NEXI/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.